Literature DB >> 19958044

Anti-trypanosomatid activity of ceragenins.

Diana Lara1, Yanshu Feng, Julia Bader, Paul B Savage, Rosa A Maldonado.   

Abstract

Cationic steroid antibiotics (CSAs), or ceragenins, are amphiphilic compounds consisting of a cholic acid backbone that is attached to several cationic amines. In this study, we tested the hypothesis that CSAs possess antiparasitic activities with minimal to no effects on mammalian cells, and thus could be used as potential therapeutic agents against pathogenic trypanosomatids. To investigate this notion, we synthesized CSAs and determined their trypanocidal and leishmanicidal activities in vitro. The 3 ceragenins assayed, i.e., CSA-8, CSA-13, and CSA-54, showed several degrees of parasiticidal activity. CSA-13 was the most effective compound against Leishmania major promastigotes and Trypanosoma cruzi trypomastigotes, at LD(50) 4.9 and 9 microM, respectively. The trypanocidal activities of these ceragenins were also assessed by infectivity experiments. We found CSA-8 was more effective on T. cruzi intracellular amastigotes when the infected host cells were treated for 24 hr (LD(50), 6.7 microM). Macrophages and LLC-MK(2) (treated for 72 hr) showed relative low susceptibility to these compounds. Our results suggest that ceragenins are indeed promising chemotherapeutic agents against trypanosomatids, but they require further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19958044      PMCID: PMC2891312          DOI: 10.1645/GE-2329.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  33 in total

1.  Origins of cell selectivity of cationic steroid antibiotics.

Authors:  Bangwei Ding; Ning Yin; Yang Liu; Jaime Cardenas-Garcia; Richard Evanson; Thomas Orsak; Mingjin Fan; Gracija Turin; Paul B Savage
Journal:  J Am Chem Soc       Date:  2004-10-27       Impact factor: 15.419

2.  The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide.

Authors:  P Díaz-Achirica; J Ubach; A Guinea; D Andreu; L Rivas
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 3.  Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites.

Authors:  J A Urbina
Journal:  Parasitology       Date:  1997       Impact factor: 3.234

Review 4.  Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa.

Authors:  C W Roberts; R McLeod; D W Rice; M Ginger; M L Chance; L J Goad
Journal:  Mol Biochem Parasitol       Date:  2003-02       Impact factor: 1.759

5.  Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors:  R A Maldonado; J Molina; G Payares; J A Urbina
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 6.  Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans.

Authors:  Anne-Laure Bañuls; Mallorie Hide; Franck Prugnolle
Journal:  Adv Parasitol       Date:  2007       Impact factor: 3.870

7.  The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease.

Authors:  J Antonio Marin-Neto; Anis Rassi; Alvaro Avezum; Antonio C Mattos; Anis Rassi; Carlos A Morillo; Sergio Sosa-Estani; Salim Yusuf
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

8.  Killing of African trypanosomes by antimicrobial peptides.

Authors:  Bradford S McGwire; Cheryl L Olson; Brian F Tack; David M Engman
Journal:  J Infect Dis       Date:  2003-06-16       Impact factor: 5.226

Review 9.  The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research.

Authors:  M A Ferguson
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

10.  The challenges of Chagas Disease-- grim outlook or glimmer of hope.

Authors:  Rick L Tarleton; Richard Reithinger; Julio A Urbina; Uriel Kitron; Ricardo E Gürtler
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

View more
  12 in total

1.  Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells.

Authors:  Eva Iniguez; Antonio Sánchez; Miguel A Vasquez; Alberto Martínez; Joanna Olivas; Aaron Sattler; Roberto A Sánchez-Delgado; Rosa A Maldonado
Journal:  J Biol Inorg Chem       Date:  2013-07-24       Impact factor: 3.358

2.  Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.

Authors:  Alberto Martínez; Teresia Carreon; Eva Iniguez; Atilio Anzellotti; Antonio Sánchez; Marina Tyan; Aaron Sattler; Linda Herrera; Rosa A Maldonado; Roberto A Sánchez-Delgado
Journal:  J Med Chem       Date:  2012-04-09       Impact factor: 7.446

3.  Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.

Authors:  K Leszczyńska; A Namiot; K Cruz; F J Byfield; E Won; G Mendez; W Sokołowski; P B Savage; R Bucki; P A Janmey
Journal:  J Appl Microbiol       Date:  2010-10-21       Impact factor: 3.772

4.  Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major.

Authors:  Eva A Iniguez; Andrea Perez; Rosa A Maldonado; Rachid Skouta
Journal:  Bioorg Med Chem Lett       Date:  2015-09-22       Impact factor: 2.823

5.  Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.

Authors:  Robert Bucki; Katarzyna Niemirowicz; Urszula Wnorowska; Fitzroy J Byfield; Ewelina Piktel; Marzena Wątek; Paul A Janmey; Paul B Savage
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

6.  Antibacterial and Antibiofilm Activities of Ceragenins against Pseudomonas aeruginosa Clinical Isolates.

Authors:  Çağla Bozkurt Güzel; Mayram Hacioğlu; Gözde Inci; Paul B Savage
Journal:  Turk J Pharm Sci       Date:  2019-11-11

7.  In Vitro Activities of the Cationic Steroid Antibiotics CSA-13, CSA-131, CSA-138, CSA-142, and CSA-192 Against Carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Çağla Bozkurt Güzel; Nevin Meltem Avci; Paul Savage
Journal:  Turk J Pharm Sci       Date:  2020-02-19

8.  Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients.

Authors:  Cagla Bozkurt-Guzel; Paul B Savage; Alper Akcali; Berna Ozbek-Celik
Journal:  Biomed Res Int       Date:  2014-03-24       Impact factor: 3.411

9.  Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.

Authors:  Bonita Durnaś; Urszula Wnorowska; Katarzyna Pogoda; Piotr Deptuła; Marzena Wątek; Ewelina Piktel; Stanisław Głuszek; Xiaobo Gu; Paul B Savage; Katarzyna Niemirowicz; Robert Bucki
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

10.  Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays.

Authors:  Cagla Bozkurt-Guzel; Gozde Inci; Ozlem Oyardi; Paul B Savage
Journal:  Curr Microbiol       Date:  2020-03-18       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.